JAZZ vs VCTR · P/E 1988, rev $4.07B vs P/E 14, rev $893.5M
Jazz Pharmaceuticals PLC (JAZZ) versus Victory Capital Holdings Inc (VCTR) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Victory Capital Holdings Inc (VCTR) is a asset management company listed on US.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported VCTR revenue for 2024-12-31 was $893.5M. Net income was $288.9M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. VCTR currently screens at market cap $4.35B and trailing P/E 14.4.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. VCTR currently screens at market cap $4.35B and trailing P/E 14.4.
Not investment advice. Open the JAZZ and VCTR stock pages for the full models.
Not investment advice.